These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 16613101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Does spironolactone use at arterial hypertension therapy protect endothelium also in smoking patients?].
    Kara-Perz H, Kosicka T, Perz S.
    Przegl Lek; 2009 Jan; 66(10):571-3. PubMed ID: 20301883
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
    Sharabi Y, Adler E, Shamis A, Nussinovitch N, Markovitz A, Grossman E.
    Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K, Topal C, Erkoc R, Sayarlioglu H, Can S, Yilmaz Y, Dogan E, Algun E, Gonulalan H.
    Ann Pharmacother; 2005 Jun 01; 39(6):1034-8. PubMed ID: 15840731
    [Abstract] [Full Text] [Related]

  • 17. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M, Vyzantiadis A, Milionis A, Memmos D, Metaxas P.
    Life Support Syst; 1983 Jun 01; 1(3):197-205. PubMed ID: 6433115
    [Abstract] [Full Text] [Related]

  • 18. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL, Kutyrina IM.
    Ter Arkh; 1999 Jun 01; 71(6):64-7. PubMed ID: 10420461
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.